Good news in the fight against cancer! This Tuesday, Moderna and Merck confirmed that Phase 2b combining a drug from the Merck lab with Moderna’s messenger RNA system into a vaccine would significantly reduce skin cancer, particularly melanoma. But be patient: Phase 3 trials and more studies are still needed. The explanation, in the note of the day.
Related posts:
Doctor Trump and Melania comments on their health after contracting the Coronavirus
Upcoming blood campaigns in the region
Skin cancer usually doesn't start with a strange mole: what should you look out for? - Health
"The Importance of Vitamin B Complex for Pregnant Women: Benefits of Vitamin B1 and B2"
